Free Trial

enVVeno Medical (NVNO) Competitors

$5.75
+0.25 (+4.55%)
(As of 07/26/2024 ET)

NVNO vs. VANI, NSPR, MBOT, OBIO, INO, UTMD, RCEL, PROF, NPCE, and DCTH

Should you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include Vivani Medical (VANI), InspireMD (NSPR), Microbot Medical (MBOT), Orchestra BioMed (OBIO), Inovio Pharmaceuticals (INO), Utah Medical Products (UTMD), AVITA Medical (RCEL), Profound Medical (PROF), NeuroPace (NPCE), and Delcath Systems (DCTH). These companies are all part of the "medical" sector.

enVVeno Medical vs.

enVVeno Medical (NASDAQ:NVNO) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, community ranking, analyst recommendations, earnings, risk, profitability and media sentiment.

In the previous week, enVVeno Medical and enVVeno Medical both had 1 articles in the media. Vivani Medical's average media sentiment score of 1.89 beat enVVeno Medical's score of 0.93 indicating that Vivani Medical is being referred to more favorably in the news media.

Company Overall Sentiment
enVVeno Medical Positive
Vivani Medical Very Positive

enVVeno Medical is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
enVVeno MedicalN/AN/A-$23.52M-$1.66-3.46
Vivani MedicalN/AN/A-$25.65M-$0.50-2.50

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
enVVeno Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Vivani Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

enVVeno Medical has a beta of 1.24, meaning that its stock price is 24% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 3.23, meaning that its stock price is 223% more volatile than the S&P 500.

enVVeno Medical received 155 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 62.65% of users gave enVVeno Medical an outperform vote.

CompanyUnderperformOutperform
enVVeno MedicalOutperform Votes
156
62.65%
Underperform Votes
93
37.35%
Vivani MedicalOutperform Votes
1
100.00%
Underperform Votes
No Votes

enVVeno Medical's return on equity of -62.17% beat Vivani Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
enVVeno MedicalN/A -62.17% -57.58%
Vivani Medical N/A -93.91%-47.76%

34.7% of enVVeno Medical shares are owned by institutional investors. Comparatively, 6.8% of Vivani Medical shares are owned by institutional investors. 17.0% of enVVeno Medical shares are owned by company insiders. Comparatively, 55.6% of Vivani Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Vivani Medical beats enVVeno Medical on 7 of the 11 factors compared between the two stocks.

Get enVVeno Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVNO vs. The Competition

MetricenVVeno MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$76.65M$3.77B$5.31B$8.19B
Dividend YieldN/A1.63%2.72%3.96%
P/E Ratio-3.4614.77152.0818.37
Price / SalesN/A64.102,071.7488.82
Price / CashN/A49.5835.8934.13
Price / Book1.664.244.954.51
Net Income-$23.52M$2.63M$112.29M$216.36M
7 Day Performance1.59%0.68%2.73%1.82%
1 Month Performance11.22%4.33%6.97%7.09%
1 Year Performance16.87%13.79%11.22%4.88%

enVVeno Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VANI
Vivani Medical
0 of 5 stars
0.00 / 5 stars
$1.28
-0.4%
N/A-3.1%$70.10MN/A-2.5520Positive News
NSPR
InspireMD
1.3701 of 5 stars
1.37 / 5 stars
$2.50
+1.6%
$4.85
+94.0%
+0.0%$62.33M$6.20M-3.2965Gap Down
MBOT
Microbot Medical
3.0054 of 5 stars
3.01 / 5 stars
$1.06
-0.9%
$7.00
+560.1%
-59.1%$16.94MN/A-1.1921Short Interest ↓
Positive News
Gap Up
OBIO
Orchestra BioMed
1.9477 of 5 stars
1.95 / 5 stars
$8.10
+0.2%
$17.00
+109.9%
+6.9%$289.90M$2.76M-5.4756Analyst Forecast
Short Interest ↑
News Coverage
INO
Inovio Pharmaceuticals
3.5169 of 5 stars
3.52 / 5 stars
$10.92
-2.3%
$56.75
+419.7%
-84.7%$282.94M$830,000.000.00122Short Interest ↑
News Coverage
Gap Up
UTMD
Utah Medical Products
3.6003 of 5 stars
3.60 / 5 stars
$77.33
+3.0%
N/A-27.2%$272.82M$49.04M17.18180Short Interest ↓
News Coverage
RCEL
AVITA Medical
1.2961 of 5 stars
1.30 / 5 stars
$10.34
-0.5%
$19.00
+83.8%
-45.3%$266.77M$50.14M-5.88207Short Interest ↑
Positive News
PROF
Profound Medical
2.0902 of 5 stars
2.09 / 5 stars
$10.87
+0.6%
$15.31
+40.9%
-10.5%$266.10M$7.20M-8.43131Analyst Forecast
News Coverage
NPCE
NeuroPace
3.159 of 5 stars
3.16 / 5 stars
$9.14
+8.0%
$14.83
+62.3%
+93.2%$262.96M$65.42M-7.68171Short Interest ↑
DCTH
Delcath Systems
2.0473 of 5 stars
2.05 / 5 stars
$8.69
flat
$19.83
+128.2%
+81.6%$241.50M$2.07M-3.2860

Related Companies and Tools

This page (NASDAQ:NVNO) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners